News

Partner companies' news

SAB Biotherapeutics Appoints Mark J. Ratain, MD, to the Company’s Board of Scientific Advisors

Acorn Management Partners, Administrator
April 2022 — 461 views SABS

Foresight Announces Fourth Quarter and Full Year 2021 Financial Results

Acorn Management Partners, Administrator
April 2022 — 439 views FRSX

KemPharm Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Corporate Updates

Acorn Management Partners, Administrator
April 2022 — 454 views KMPH

SAB Biotherapeutics Provides Company Update and Reports Full Year 2021 Financial Results

Acorn Management Partners, Administrator
April 2022 — 419 views SABS

KemPharm to Participate in Maxim’s 2022 Virtual Growth Conference

Acorn Management Partners, Administrator
March 2022 — 477 views KMPH

KemPharm Announces Full Data Set from Higher-Dose Serdexmethylphenidate (SDX) Phase 1 Clinical Trial

Acorn Management Partners, Administrator
March 2022 — 455 views KMPH

KemPharm Earns $1.975 Million Fee from Corium Following FDA Approval of the Corium Product ADLARITY® (donepezil transdermal system)

Acorn Management Partners, Administrator
March 2022 — 433 views KMPH

Foresight to Present and Participate in a Panel Discussion at the Maxim Group Virtual Growth Conference

Acorn Management Partners, Administrator
March 2022 — 460 views FRSX

KemPharm to Report Fourth Quarter and Full-Year 2021 Results

Acorn Management Partners, Administrator
March 2022 — 477 views KMPH

Foresight’s Technology to Replace Use of LiDAR by a Leading Israeli Defense Integrator for the Israeli Defense Forces

Acorn Management Partners, Administrator
February 2022 — 462 views FRSX

KemPharm Completes KP1077 Pre-IND Meeting Process with FDA

Acorn Management Partners, Administrator
February 2022 — 462 views KMPH

Foresight: Eye-Net Selected by Paris2Connect Consortium to Participate in an Urban Mobility Experiment, Consortium Members Include Nokia, ATC France, Aximum, RATP Group and Signify

Acorn Management Partners, Administrator
February 2022 — 424 views FRSX

Foresight Collaborates with a Leading Tier One Supplier on Enhancing ADAS Vision Systems

Acorn Management Partners, Administrator
February 2022 — 501 views FRSX

KemPharm Issues Letter to Shareholders Detailing Strategic Focus on CNS/Rare Disease Indications and Updated Clinical Development Strategy

Acorn Management Partners, Administrator
January 2022 — 447 views KMPH

Foresight and SUNWAY-AI Collaborate to Commercialize Autonomous Technologies to the Chinese Agriculture Market

Acorn Management Partners, Administrator
January 2022 — 425 views FRSX

KemPharm to Host Investor Conference Call Detailing Plans for Pipeline Expansion

Acorn Management Partners, Administrator
January 2022 — 464 views KMPH

KemPharm Announces Research Involving Serdexmethylphenidate to be Featured in Two Poster Presentations at the APSARD 2022 Annual Conference

Acorn Management Partners, Administrator
January 2022 — 455 views KMPH

Foresight: Eye-Net Enters Indian Market with Pilot Project for Fleet Telematics

Acorn Management Partners, Administrator
January 2022 — 492 views FRSX

KemPharm to Participate in BIO Partnering @ JPM During “J.P. Morgan Week 2022”

Acorn Management Partners, Administrator
January 2022 — 485 views KMPH

Foresight Expands Chinese Market Presence with Establishment of Local Subsidiary

Acorn Management Partners, Administrator
January 2022 — 561 views FRSX

About us

Helping America invest in you:

Connecting your company stock with professional market participants.

One call at a time

Stay updated :

Participate on our social stream.

Our Blogs

Tags

Archives